News

Leo Lens Pharma Expands Its Scientific Advisory Board

External Thought Leaders to Help Guide Progress on Company’s

Araceli Richardson2021-03-31T23:03:25+00:0008.05.2020|

Leo Lens Pharma Excited to be a Presenting Company at OTS 2020

Araceli Richardson2021-03-31T23:07:27+00:0007.17.2020|

Leo Lens Pharma Excited to Have Its Lead Asset Ready for Human Clinical Evaluation

Patented product for the novel treatment of glaucoma is

Araceli Richardson2021-03-31T23:08:42+00:0006.23.2020|

Leo Lens Pharma Proud to Be Selected as a Connect 2020 Cool Company

Araceli Richardson2021-03-31T23:12:15+00:0005.29.2020|

Leo Lens Pharma Appoints Dan Myers CEO

Accomplished Ophthalmic Executive to Lead Company in Its Next PhaseSAN

Araceli Richardson2021-03-31T23:13:40+00:0004.15.2020|

Myopia Management Focus of Pipeline Expansion for Leo Lens Pharma

Leo Lens Pharma Strengthens its Pipeline with New IP

Araceli Richardson2021-03-31T23:15:12+00:0002.20.2020|

Leo Lens Technology Selected as Finalist for Connect’s 2019 Most Innovative New Product Awards

FOR IMMEDIATE RELEASELeo Lens Technology Selected as Finalist for Connect’s

Araceli Richardson2021-03-31T23:16:14+00:0011.12.2019|

Biocom Member Spotlight: Interview with Kokila & Praful Doshi, Co-Founders of Leo Lens Technology

Leo Lens was featured in a Member Spotlight article from

Araceli Richardson2021-03-31T23:18:29+00:0009.05.2019|

Leo Lens Selected as Presenting Company at Octane MTIF 2018

Leo Lens was selected from over 150 companies to be

Araceli Richardson2021-03-31T23:19:30+00:0010.10.2018|